← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bexion Pharmaceuticals, Inc.
Covington, KY
$4,887,004
Total funding
4
Grants
Funding over time
peak $960.3K · FY2007–15$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,887,004 · 4
By mechanism
R44$4,368,595 · 1
R43$518,409 · 3
Investigators at Bexion Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$960,270
R44 · FY2013 · CA
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$948,501
R44 · FY2014 · CA
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$948,501
R44 · FY2015 · CA
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme$840,956
R44 · FY2011 · CA
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme$670,367
R44 · FY2010 · CA
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$273,138
R43 · FY2008 · CA
A novel biotherapeutic treatment for prostate cancer$145,306
R43 · FY2007 · CA
A Novel Biotherapeutic Treatment for Pancreatic Cancer$99,965
R43 · FY2008 · CA